We are live on ! Find out more
NVNO

enVVeno Medical
NVNO

22 hedge funds and large institutions have $13.7M invested in enVVeno Medical in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,263% more call options, than puts

Call options by funds: $3.38M | Put options by funds: $63K

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

69% more capital invested

Capital invested by funds: $8.11M → $13.7M (+$5.62M)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

5% more funds holding

Funds holding: 21 → 22 (+1)

0.01% more ownership

Funds ownership: 0.65% → 0.66% (+0.01%)

Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
6
Reduced
2
Closed
2
Calls
$3.38M
Puts
$63K
Net Calls
+$3.32M
Net Calls Change
+$1.68M

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$192K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$131K
3
Citadel Advisors
Citadel Advisors
Florida
+$122K
4
Morgan Stanley
Morgan Stanley
New York
+$24.3K
5
TRCT
Tower Research Capital (TRC)
New York
+$13K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$119K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$67.9K
3
Millennium Management
Millennium Management
New York
-$40K
4
Osaic Holdings
Osaic Holdings
Arizona
-$1.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$4.91M – – –
ACM
2
ACT Capital Management
Pennsylvania
$2.52M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.11M – – –
KCM
4
Kingdon Capital Management
New York
$1.38M – – –
UOC
5
UBS O'Connor
Illinois
$940K +$192K +903 +27%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$516K +$2.77K +13 +0.6%
BlackRock
7
BlackRock
New York
$211K +$1.49K +7 +0.7%
Morgan Stanley
8
Morgan Stanley
New York
$203K +$24.3K +114 +14%
AMCA
9
Arthur M. Cohen & Associates
Illinois
$151K – – –
State Street
10
State Street
Massachusetts
$135K – – –
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$135K +$131K +614 New
Citadel Advisors
12
Citadel Advisors
Florida
$126K +$122K +571 New
Two Sigma Advisers
13
Two Sigma Advisers
New York
$110K -$119K -557 -53%
Northern Trust
14
Northern Trust
Illinois
$87K – – –
Osaic Holdings
15
Osaic Holdings
Arizona
$72K -$1.06K -5 -2%
SC
16
Sepio Capital
Utah
$68K – – –
FP
17
Financial Perspectives
Minnesota
$20.6K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$17K +$13K +61 +407%
Wells Fargo
19
Wells Fargo
California
$13K – – –
UBS Group
20
UBS Group
Switzerland
$11K +$8.52K +40 +500%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
– -$67.9K -319 Closed
Millennium Management
22
Millennium Management
New York
– -$40K -304 Closed
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
– +$426 +2 New

NVNO Hedge Fund Activity: Q3 2022 in Review

22 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2022, worth a combined $13.7M — up 69% from $8.11M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NVNO positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $192K. The largest seller was Two Sigma Advisers, cutting an estimated $119K.

  • 22 institutional investors held enVVeno Medical (NVNO) as of Q3 2022, up from 21 in Q2 2022.
  • Funds reported $13.7M of enVVeno Medical stock for Q3 2022, up 69% quarter-over-quarter.
  • 3 funds opened new enVVeno Medical positions in Q3 2022 and 2 closed out, a net change of +1 holder.
  • The largest enVVeno Medical buyer in Q3 2022 was UBS O'Connor, an estimated $192K added.
  • The largest enVVeno Medical seller in Q3 2022 was Two Sigma Advisers, an estimated $119K sold.

Based on aggregated 13F filings for Q3 2022.